Ernest T Hawk

Ernest T Hawk

UNVERIFIED PROFILE

Are you Ernest T Hawk?   Register this Author

Register author
Ernest T Hawk

Ernest T Hawk

Publications by authors named "Ernest T Hawk"

Are you Ernest T Hawk?   Register this Author

78Publications

1258Reads

25Profile Views

E-Cigarettes: Unstandardized, Under-Regulated, Understudied, and Unknown Health and Cancer Risks.

Cancer Res 2019 Dec 28;79(24):6079-6083. Epub 2019 Oct 28.

Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-19-2997DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6911629PMC
December 2019

Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.

EBioMedicine 2019 Apr 21;42:296-303. Epub 2019 Mar 21.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.03.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491940PMC
April 2019

Bioactive lipid metabolism in platelet "first responder" and cancer biology.

Cancer Metastasis Rev 2018 09;37(2-3):439-454

Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-018-9755-8DOI Listing
September 2018

Perspectives on Strengthening Cancer Research and Control in Latin America Through Partnerships and Diplomacy: Experience of the National Cancer Institute's Center for Global Health.

J Glob Oncol 2018 09;4:1-11

Silvina Frech, Catherine A. Muha, Lisa M. Stevens, Edward L. Trimble, Roxanne Brew, Doug Puricelli Perin, Paul C. Pearlman, and Brenda Kostelecky, National Cancer Institute, Rockville, MD; Silvana Luciani, Pan American Health Organization; Cristina Rabadan-Diehl, US Department of Health and Human Services; Denise Duran, Centers for Disease Control and Prevention, Washington, DC; Alejandro Mohar, Instituto Nacional de Cancerología, Mexico City, Mexico; Marion Piñeros, International Agency for Research on Cancer, Lyon, France; Tatiana Vidaurre, Instituto Nacional de Enfermedades Neoplásicas, Surquillo, Peru; Douglas R. Morgan, Vanderbilt-Ingram Cancer Center, Nashville, TN; Ernest T. Hawk, Kathleen M. Schmeler, Lewis E. Foxhall, and Melissa S. Lopez, The University of Texas MD Anderson Cancer Center, Houston, TX; Melissa Rendler-Garcia, Union for International Cancer Control, Geneva, Switzerland; Eduardo L. Cazap, Sociedad Latinoamericana y del Caribe del Oncología Médica, Buenos Aires, Argentina; Luiz Santini and Walter Zoss, Red de Institutos e Instituciones Nacionales de Cáncer, Sao Paolo, Brazil; Lucia B. Delgado, Universidad de la República, Montevideo, Uruguay; and Leslie Given and Karin Hohman, Strategic Health Concepts, Arvada, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.17.00149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223440PMC
September 2018

Project ECHO: A Telementoring Program for Cervical Cancer Prevention and Treatment in Low-Resource Settings.

J Glob Oncol 2017 Oct 5;3(5):658-665. Epub 2016 Oct 5.

, , , , and , The University of Texas MD Anderson Cancer Center, Houston; , Su Clinica Familiar, Brownsville; , The University of Texas Medical Branch, Galveston, TX; , Hospital Central de Maputo, Maputo, Mozambique; , , Cancer Diseases Hospital, Lusaka, Zambia; , , , and , Hospital de Cancer de Barretos, Barretos; , , , and , Hospital Israelita Albert Einstein; , A.C. Camargo Cancer Center, Sao Paulo; , Federal University of Health Sciences/Santa Casa de Misericordia, Porto Alegre, Brazil; and , Universidad de la Republica, Montevideo, Uruguay; , Basic Health International, San Salvador, El Salvador; and , University of New Mexico, Albuquerque, NM.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JGO.2016.005504
Publisher Site
http://dx.doi.org/10.1200/JGO.2016.005504DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646881PMC
October 2017

Building trust and diversity in patient-centered oncology clinical trials: An integrated model.

Clin Trials 2017 Apr 7;14(2):170-179. Epub 2017 Feb 7.

5 Department of Life Sciences, College of Science and Engineering, Texas A&M University-Corpus Christi, Corpus Christi, TX, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1740774516688860
Publisher Site
http://dx.doi.org/10.1177/1740774516688860DOI Listing
April 2017

Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic.

Open Heart 2017 28;4(1):e000550. Epub 2017 Apr 28.

Baylor College of Medicine, USDA/ARS Children's Nutrition Research Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/openhrt-2016-000550DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471872PMC
April 2017

Assessment of Compliance With Texas Legislation Banning Indoor UV Tanning by Minors.

JAMA Dermatol 2017 Feb;153(2):228-229

Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2016.4068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484732PMC
February 2017

Ernest Hawk Discusses the NCI-Designated Cancer Centers' Joint Statement on the HPV Vaccine.

Authors:
Ernest T Hawk

Oncology (Williston Park) 2016 Jul;30(7):599-600

View Article

Download full-text PDF

Source
July 2016

Aspirin for Cancer Prevention: One Step Closer.

JAMA Oncol 2016 Jun;2(6):770-1

Division of Cancer Prevention and Population Sciences, Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.6395DOI Listing
June 2016

Genomic Landscape of Colorectal Mucosa and Adenomas.

Cancer Prev Res (Phila) 2016 06 24;9(6):417-27. Epub 2016 May 24.

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-16-0081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941624PMC
June 2016

Germline Genetic Variants in the Wnt/β-Catenin Pathway as Predictors of Colorectal Cancer Risk.

Cancer Epidemiol Biomarkers Prev 2016 Mar 25;25(3):540-6. Epub 2016 Jan 25.

Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0834DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779688PMC
March 2016

When "Effective" Prevention Agents Fail to Elicit Anticipated Effects: Challenges in Trial Design.

Cancer Prev Res (Phila) 2016 Feb 29;9(2):125-7. Epub 2015 Dec 29.

Department of Clinical Cancer Prevention, Division of Cancer Prevention and Population Sciences, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-15-0432DOI Listing
February 2016

Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.

Semin Oncol 2016 Feb 10;43(1):65-77. Epub 2015 Sep 10.

The University of Texas MD Anderson Cancer Center, Division of Cancer Prevention and Population Sciences, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2015.09.010DOI Listing
February 2016

Molecular cancer prevention: Current status and future directions.

CA Cancer J Clin 2015 Sep-Oct;65(5):345-83. Epub 2015 Aug 18.

Vice President and Division Head, Boone Pickens Distinguished Chair for Early Prevention of Cancer, Division of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21287DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820069PMC
December 2015

Convergence of nanotechnology and cancer prevention: are we there yet?

Cancer Prev Res (Phila) 2014 Oct 24;7(10):973-92. Epub 2014 Jul 24.

Division of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-14-0079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307396PMC
October 2014

Urinary PGE-M in colorectal cancer: predicting more than risk?

Cancer Prev Res (Phila) 2014 Oct 28;7(10):969-72. Epub 2014 Jul 28.

Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-14-0215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185234PMC
October 2014

Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.

Carcinogenesis 2013 Dec 29;34(12):2750-6. Epub 2013 Aug 29.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgt286DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845893PMC
December 2013

Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma.

Cancer 2012 Dec 6;118(24):6188-98. Epub 2012 Jun 6.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27653DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465518PMC
December 2012

Intake of red meat and heterocyclic amines, metabolic pathway genes and bladder cancer risk.

Int J Cancer 2012 Oct 6;131(8):1892-903. Epub 2012 Mar 6.

Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.27437
Publisher Site
http://dx.doi.org/10.1002/ijc.27437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415602PMC
October 2012

Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma.

Carcinogenesis 2012 Apr 8;33(4):841-7. Epub 2012 Feb 8.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgs096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324446PMC
April 2012

The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma.

Cancer Prev Res (Phila) 2012 Jan 26;5(1):61-72. Epub 2011 Oct 26.

Gastrointestinal Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252487PMC
January 2012

Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention.

Cancer Prev Res (Phila) 2011 Nov 21;4(11):1728-35. Epub 2011 Jul 21.

Department of Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Science Park, PO Box 389, Smithville, TX 78957, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0166DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208782PMC
November 2011

C-reactive protein and risk of colorectal adenoma according to celecoxib treatment.

Cancer Prev Res (Phila) 2011 Aug;4(8):1172-80

Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-10-0403DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151679PMC
August 2011

Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis.

Cancer Prev Res (Phila) 2010 Sep 22;3(9):1176-86. Epub 2010 Jul 22.

Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Unit 1340, 1155 Pressler Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-09-0265DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932797PMC
September 2010

Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.

Cancer Prev Res (Phila) 2010 May 19;3(5):588-96. Epub 2010 Apr 19.

Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-09-0271DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990920PMC
May 2010

Energy balance, the PI3K-AKT-mTOR pathway genes, and the risk of bladder cancer.

Cancer Prev Res (Phila) 2010 Apr 30;3(4):505-17. Epub 2010 Mar 30.

Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, 1155 Hermann Pressler Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/cgi/doi/10.
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-09-0263DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867666PMC
April 2010

Cancer prevention: from 1727 to milestones of the past 100 years.

Cancer Res 2009 Jul 2;69(13):5269-84. Epub 2009 Jun 2.

Department of Thoracic/Head and Neck Medical Oncology, Unit 432, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-1750DOI Listing
July 2009

Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma.

Gastroenterology 2009 Jun 21;136(7):2127-2136.e1. Epub 2009 Feb 21.

Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2009.02.045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693443PMC
June 2009

The Translational Research Working Group developmental pathways: introduction and overview.

Clin Cancer Res 2008 Sep 8;14(18):5664-71. Epub 2008 Jul 8.

Office of Centers, Training, and Resources, National Cancer Institute, Rockville, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1268DOI Listing
September 2008

Translational Research Working Group developmental pathway for biospecimen-based assessment modalities.

Clin Cancer Res 2008 Sep;14(18):5672-7

Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2737183PMC
September 2008

Aberrant crypt foci in the adenoma prevention with celecoxib trial.

Cancer Prev Res (Phila) 2008 Jun 14;1(1):21-31. Epub 2008 Apr 14.

Department of Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-07-0011DOI Listing
June 2008

Statins in esophageal cancer cell lines: promising lead?

Am J Gastroenterol 2008 Apr 24;103(4):838-41. Epub 2008 Mar 24.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1572-0241.2007.01768.xDOI Listing
April 2008

Do statins prevent cancer?

Nat Clin Pract Oncol 2006 Sep;3(9):478-9

Office of Centers, Training and Resources at the National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0586DOI Listing
September 2006

A methodologic analysis of chemoprevention and cancer prevention strategies for gastrointestinal cancer.

Nat Clin Pract Gastroenterol Hepatol 2006 Feb;3(2):101-11

Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford University, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpgasthep0412DOI Listing
February 2006

Can animal models help us select specific compounds for cancer prevention trials?

Recent Results Cancer Res 2005 ;166:71-87

GI and Other Cancers Research Group, National Cancer Institute, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892-7317, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/3-540-26980-0_6DOI Listing
February 2005

Prevention and therapy of colorectal cancer.

Med Clin North Am 2005 Jan;89(1):85-110, viii

Gastrointestinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892-7317, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mcna.2004.08.003DOI Listing
January 2005

Colorectal cancer prevention.

J Clin Oncol 2005 Jan;23(2):378-91

GI and Other Cancers Research Group, National Cancer Institute, 6130 Executive Boulevard, Suite 2141, Bethesda, MD 20892-7322, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2005.08.097
Publisher Site
http://dx.doi.org/10.1200/JCO.2005.08.097DOI Listing
January 2005

Non-steroidal anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention.

Cancer Chemother Biol Response Modif 2003 ;21:759-89

National Cancer Institute, Division of Cancer Prevention, Bethesda, MD 20892-7317, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0921-4410(03)21036-xDOI Listing
September 2004

Irreversible ototoxicity associated with difluoromethylornithine.

Cancer Epidemiol Biomarkers Prev 2004 Jul;13(7):1250-2

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, 48109, USA.

View Article

Download full-text PDF

Source
July 2004

Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.

Cancer Epidemiol Biomarkers Prev 2004 Jun;13(6):920-7

Department of Gastrointestinal Medicine and Nutrition, University of Texas M. D. Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
June 2004

Colorectal cancer chemoprevention--an overview of the science.

Gastroenterology 2004 May;126(5):1423-47

Gastrointentinal and Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute/NIH, EPN Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892-7317, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2004.03.002DOI Listing
May 2004

Serum proteomic profiles suggest celecoxib-modulated targets and response predictors.

Cancer Res 2004 Apr;64(8):2904-9

Laboratory of Proteomics and Analytical Technologies and Advanced Biomedical Computing Center, SAIC-Frederick Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.can-03-3754DOI Listing
April 2004

Testing guidelines for hereditary non-polyposis colorectal cancer.

Nat Rev Cancer 2004 02;4(2):153-8

Division of Cancer Prevention and Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc1278DOI Listing
February 2004

Cyclooxygenase inhibition in cancer prevention and treatment.

Expert Opin Pharmacother 2003 Dec;4(12):2193-204

Gastrointestinal & Other Cancers Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, EPN, Room 2141, 6130 Executive Boulevard, Bethesda, MD 20892-7317, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.4.12.2193DOI Listing
December 2003

Frontiers in cancer prevention research.

Cancer Res 2003 Sep;63(18):5649-55

Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
September 2003

Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials.

Prog Exp Tumor Res 2003 ;37:210-42

Gastrointestinal & Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, Bethesda, Md., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000071375DOI Listing
August 2003

Development of COX inhibitors in cancer prevention and therapy.

Am J Clin Oncol 2003 Aug;26(4):S48-57

Gastrointestinal & Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, Bethesda, Maryland 20892-7317, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/amjclinicaloncology/2003/08002/
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/01.COC.0000074157.28792.02DOI Listing
August 2003

Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers.

Cancer Epidemiol Biomarkers Prev 2003 Jul;12(7):593-6

National Cancer Institute, Division of Cancer Treatment and Diagnosis, Biomedical Imaging Program, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
July 2003

Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer.

Mutat Res 2003 Feb-Mar;523-524:137-44

Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892-7322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0027-5107(02)00329-9DOI Listing
April 2003

Chemoprevention of colorectal cancer: problems, progress, and prospects.

Gastroenterol Clin North Am 2002 Dec;31(4):971-99

Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892-7317, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0889-8553(02)00055-9DOI Listing
December 2002

Epidemiology and prevention of colorectal cancer.

Surg Clin North Am 2002 Oct;82(5):905-41

Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892-7317, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0039-6109(02)00046-4DOI Listing
October 2002

The role of cyclooxygenase inhibitors in cancer prevention.

Curr Pharm Des 2002 ;8(12):1035-62

Gastrointestinal & Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, EPN, Room 2141, 6130 Executive Boulevard, Bethesda, MD 20892-7317, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612023394935DOI Listing
August 2002

COX-2 in cancer--a player that's defining the rules.

J Natl Cancer Inst 2002 Apr;94(8):545-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/94.8.545DOI Listing
April 2002

Chemoprevention of colorectal carcinogenesis.

Int J Clin Oncol 2002 Feb;7(1):2-26

Gastrointestinal and Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD 20892-7317, USA.

View Article

Download full-text PDF

Source
http://link.springer.de/link/service/journals/10147/bibs/200
Publisher Site
http://dx.doi.org/10.1007/s101470200001DOI Listing
February 2002